Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Catabasis Pharma. Cm

NASDAQ: CATBHealthcare / Biotechnology / USA
1.59-0.02-1.24%Vol 124 7401Y Perf 16.91%
May 25th, 2018 16:00
BID1.59 ASK1.61
Open1.60 Previous Close1.61
Pre-Market- After-Trading1.59
 - -%  - -%
Target Price
5.50 
Analyst Rating
Strong Buy 1.00
Potencial %
245.91 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)46 
Earnings Rating
Price Range Ratio 52wk %
18.59 
Earnings Date

Today's Price Range

1.561.61

 

52wk Range

1.093.78

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Month
-1.24%
3 Months
-8.09%
6 Months
-14.05%
1 Year
16.91%
3 Years
-
5 Years
-
Last Quotes
Name / TickerPriceChg.Chg.%
CATB1.59-0.0200-1.24
AAPL188.580.43000.23
GOOG1 075.66-3.5800-0.33
MSFT98.360.05000.05
XOM78.71-1.5600-1.94
WFC54.900.23000.42
JNJ121.470.12000.10
FB184.92-1.0100-0.54
GE14.630.03000.21
JPM110.66-0.5700-0.51
...

TickerPriceChg.%52 Week High
FL55.7420.1660.64
DGX105.814.88112.96
LH182.143.84184.33
LEN53.393.7572.17
ALK61.873.3495.75
LUV52.863.2266.99
AAL44.913.1059.08
RCL109.802.91135.65
K65.232.7174.28
DAL55.872.7060.79
AVGO250.032.67285.68
UA18.882.6621.81
INCY68.432.64140.11
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 3.20
Current Ratio 3.40
Long Term Debt to Total Capital 0.04
Total Debt to Equity 0.13
Interest Coverage -72.40
Leverage Ratio 1.50
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-5 354.00
EBITDA Margin-5 298.40
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 3.64
PS Ratios 94.08
Price to Cash Flow -
Price to Free Cash Flow -1.80
Cash Flow Per Share -1.09
Price to Tangible Book3.64
Book Value per Share0.45
Enterprise Value (in ths.)31 665
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)401.75
ROE last 12 Months -147.16
Return on Assets (5Y Avg) -105.24
ROA last 12 Months -104.97
Return on Capital (5Y Avg) -
ROC last 12 Months -128.08
Return on invested Capital Q -52.64
Return on invested Capital Y-116.15
Assets Turnover0.00
Receivables Turnover-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)500
Revenue per Share 0.02
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q01 2018-0.23-0.29-26.09
Q04 2017-0.31-0.2422.58
Q03 2017-0.34-0.318.82
Q02 2017-0.39-0.3217.95
Q01 2017-0.45-0.418.89
Q04 2016-0.49-0.474.08
Q03 2016-0.65-0.5416.92
Q02 2016-0.64-0.614.69
Earnings Per EndEstimateRevision %Trend
6/2018 QR-0.27-17.39Negative
9/2018 QR-0.2411.11Positive
12/2018 FY-1.044.59Positive
12/2019 FY-1.567.14Positive
Next Report Date10th May 2018
Estimated EPS Next Report-0.23
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume124 740
Shares Outstanding (in ths.)29 030
Trades Count171
Dollar Volume144 643
Avg. Volume680 533
Avg. Weekly Volume80 103
Avg. Monthly Volume164 071
Avg. Quarterly Volume319 519

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

29%71%

Bearish Bullish

56%44%

Bearish Bullish

25%75%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
3 (100.00 %)
3 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

x